• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNAi 介导的 CRISPR 功能调控。

RNAi-mediated control of CRISPR functions.

机构信息

National and Local Joint Engineering Laboratory of Medical Synthetic Biology, Shenzhen, Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen518035, China.

Department of Urology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen518035, China.

出版信息

Theranostics. 2020 May 17;10(15):6661-6673. doi: 10.7150/thno.44880. eCollection 2020.

DOI:10.7150/thno.44880
PMID:32550896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7295050/
Abstract

CRISPR-Cas9 has become a versatile tool for genome editing and regulation, and strategies to effectively control its activity have attracted much attention. RNAi, also a gene-regulating tool, is used as another mechanism by which eukaryotes resist the invasion of foreign genetic material. : In this study, we analyzed the quantitative inhibition of the CRISPR system by using artificial miRNAs (amiRNAs) combined with the RNAi enhancer enoxacin to improve the targeting specificity of the CRISPR system. Furthermore, we examined the feasibility of improving the efficiency of gene editing and regulation by blocking the effects of natural intracellular miRNAs on sgRNAs. : amiRNAs targeting the sgRNA were used to control its expression, and the small molecule drug denoxacin was utilized to enhance this effect, especially in the presence of Cas9. amiRNA/enoxacin inhibited CRISPR-mediated gene editing and regulation both and and could tune sgRNA-targeting specificity. Furthermore, CRISPR efficiency was increased by blocking the effects of endogenous miRNAs. : Our study provides an efficient molecular switch for conditional regulation of CRISPR activities in mammalian cells and also presents potentially useful approaches for solving current key issues of off-target effects and low targeting efficiency.

摘要

CRISPR-Cas9 已成为基因组编辑和调控的通用工具,有效控制其活性的策略引起了广泛关注。RNAi 也是一种基因调控工具,被真核生物用来抵抗外来遗传物质的入侵。在这项研究中,我们分析了利用人工 microRNA(amiRNA)结合 RNAi 增强剂恩诺沙星抑制 CRISPR 系统的定量抑制作用,以提高 CRISPR 系统的靶向特异性。此外,我们还研究了通过阻断天然细胞内 microRNA 对 sgRNA 的影响来提高基因编辑和调控效率的可行性。针对 sgRNA 的 amiRNA 用于控制其表达,小分子药物恩诺沙星增强了这种作用,特别是在 Cas9 存在的情况下。amiRNA/恩诺沙星抑制了 CRISPR 介导的基因编辑和调控,既能调节 sgRNA 的靶向特异性。此外,通过阻断内源性 miRNAs 的作用可以提高 CRISPR 的效率。本研究为哺乳动物细胞中 CRISPR 活性的条件调节提供了一种有效的分子开关,也为解决当前关键的脱靶效应和低靶向效率问题提供了潜在的有用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/3d8ff8c09ea9/thnov10p6661g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/708043b56675/thnov10p6661g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/8d6b01edc8f5/thnov10p6661g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/6490a71854ee/thnov10p6661g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/b5e21da6a610/thnov10p6661g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/edc8be35fafe/thnov10p6661g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/769abe4fdfdd/thnov10p6661g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/3d8ff8c09ea9/thnov10p6661g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/708043b56675/thnov10p6661g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/8d6b01edc8f5/thnov10p6661g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/6490a71854ee/thnov10p6661g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/b5e21da6a610/thnov10p6661g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/edc8be35fafe/thnov10p6661g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/769abe4fdfdd/thnov10p6661g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b11/7295050/3d8ff8c09ea9/thnov10p6661g007.jpg

相似文献

1
RNAi-mediated control of CRISPR functions.RNAi 介导的 CRISPR 功能调控。
Theranostics. 2020 May 17;10(15):6661-6673. doi: 10.7150/thno.44880. eCollection 2020.
2
CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.CRISPR/Cas9 介导的 2-sgRNA 切割促进伪狂犬病病毒编辑。
FASEB J. 2018 Aug;32(8):4293-4301. doi: 10.1096/fj.201701129R. Epub 2018 Mar 6.
3
SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing.基于 miRNA 多顺反子的 CRISPR-Cas9 系统 sgRNA 表达作为一种灵活的工具来操控多种组织特异性基因组编辑。
Sci Rep. 2017 Jul 19;7(1):5795. doi: 10.1038/s41598-017-06216-w.
4
Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.依赖于强力霉素的 CRISPR-Cas9 自我失活以时间调节靶标和非靶标编辑。
Mol Ther. 2020 Jan 8;28(1):29-41. doi: 10.1016/j.ymthe.2019.09.006. Epub 2019 Sep 12.
5
CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci.CRISPR-Switch 通过 Cre 重组调控 sgRNA 活性,用于两个基因座的顺序编辑。
Nat Commun. 2019 Nov 29;10(1):5454. doi: 10.1038/s41467-019-13403-y.
6
sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.sgRNA 序列基序阻碍高效的 CRISPR/Cas9 介导的基因编辑。
Cell Rep. 2019 Jan 29;26(5):1098-1103.e3. doi: 10.1016/j.celrep.2019.01.024.
7
"Split-and-Click" sgRNA."分割点击" sgRNA。
Methods Mol Biol. 2021;2162:61-78. doi: 10.1007/978-1-0716-0687-2_5.
8
Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption.使用 CRISPR/Cas9 经 AAV9 介导的短向导 RNA 传递进行产后心脏基因编辑导致嵌合基因破坏。
Circ Res. 2017 Oct 27;121(10):1168-1181. doi: 10.1161/CIRCRESAHA.116.310370. Epub 2017 Aug 29.
9
[CRISPR/CAS9, the King of Genome Editing Tools].[CRISPR/CAS9,基因组编辑工具之王]
Mol Biol (Mosk). 2017 Jul-Aug;51(4):582-594. doi: 10.7868/S0026898417040036.
10
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.CRISPR 卫士使用短向导 RNA 保护非靶位点免受 Cas9 核酸酶活性的影响。
Nat Commun. 2020 Aug 17;11(1):4132. doi: 10.1038/s41467-020-17952-5.

引用本文的文献

1
The Emerging Applications of Artificial MicroRNA-Mediated Gene Silencing in Plant Biotechnology.人工微小RNA介导的基因沉默在植物生物技术中的新兴应用
Noncoding RNA. 2025 Mar 2;11(2):19. doi: 10.3390/ncrna11020019.
2
Non-coding RNAs as therapeutic targets in cancer and its clinical application.非编码RNA作为癌症的治疗靶点及其临床应用。
J Pharm Anal. 2024 Jul;14(7):100947. doi: 10.1016/j.jpha.2024.02.001. Epub 2024 Feb 8.
3
Non-Coding RNA in Tumor Cells and Tumor-Associated Myeloid Cells-Function and Therapeutic Potential.

本文引用的文献

1
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.基于 CRISPR/Cas 的基因治疗在人类遗传性疾病中的进展。
Theranostics. 2020 Mar 15;10(10):4374-4382. doi: 10.7150/thno.43360. eCollection 2020.
2
Multiplexed promoterless gene expression with CRISPReader.利用 CRISPReader 进行多重无启动子基因表达。
Genome Biol. 2019 Jun 3;20(1):113. doi: 10.1186/s13059-019-1712-5.
3
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.CRISPR 引导的 DNA 碱基编辑器诱导的转录组范围的脱靶 RNA 编辑。
肿瘤细胞和肿瘤相关髓系细胞中的非编码 RNA——功能和治疗潜力。
Int J Mol Sci. 2024 Jul 2;25(13):7275. doi: 10.3390/ijms25137275.
4
The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives.一种知名抗生素的新面貌:依诺沙星及其衍生物的抗癌活性综述
Cancers (Basel). 2022 Jun 22;14(13):3056. doi: 10.3390/cancers14133056.
5
gene editing using an all-in-one self-cleavage AAV-CRISPR system.使用一体化自切割腺相关病毒-成簇规律间隔短回文重复序列系统进行基因编辑。
Mol Ther Methods Clin Dev. 2021 Feb 9;20:652-659. doi: 10.1016/j.omtm.2021.02.005. eCollection 2021 Mar 12.
6
A Blue Light-Inducible CRISPR-Cas9 System for Inhibiting Progression of Melanoma Cells.一种用于抑制黑色素瘤细胞进展的蓝光诱导型CRISPR-Cas9系统。
Front Mol Biosci. 2020 Nov 19;7:606593. doi: 10.3389/fmolb.2020.606593. eCollection 2020.
7
CRISPR-Sunspot: Imaging of endogenous low-abundance RNA at the single-molecule level in live cells.CRISPR-太阳黑子:在活细胞中单分子水平对内源性低丰度 RNA 的成像。
Theranostics. 2020 Sep 2;10(24):10993-11012. doi: 10.7150/thno.43094. eCollection 2020.
8
An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification.一种超灵敏杂交链式反应扩增 CRISPR-Cas12a 适体传感器,用于细胞外囊泡表面蛋白定量分析。
Theranostics. 2020 Aug 13;10(22):10262-10273. doi: 10.7150/thno.49047. eCollection 2020.
9
Targeting Long Non-coding RNA to Therapeutically Regulate Gene Expression in Cancer.靶向长链非编码RNA以治疗性调控癌症中的基因表达
Mol Ther Nucleic Acids. 2020 Sep 4;21:712-724. doi: 10.1016/j.omtn.2020.07.005. Epub 2020 Jul 10.
Nature. 2019 May;569(7756):433-437. doi: 10.1038/s41586-019-1161-z. Epub 2019 Apr 17.
4
Slicing and dicing viruses: antiviral RNA interference in mammals.切割病毒:哺乳动物中的抗病毒 RNA 干扰。
EMBO J. 2019 Apr 15;38(8). doi: 10.15252/embj.2018100941. Epub 2019 Mar 14.
5
A microRNA-inducible CRISPR-Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool.一种微 RNA 诱导的 CRISPR-Cas9 平台可作为微 RNA 传感器和细胞类型特异性基因组调控工具。
Nat Cell Biol. 2019 Apr;21(4):522-530. doi: 10.1038/s41556-019-0292-7. Epub 2019 Feb 25.
6
Manipulating plant RNA-silencing pathways to improve the gene editing efficiency of CRISPR/Cas9 systems.操纵植物 RNA 沉默途径以提高 CRISPR/Cas9 系统的基因编辑效率。
Genome Biol. 2018 Sep 28;19(1):149. doi: 10.1186/s13059-018-1529-7.
7
Metazoan MicroRNAs.后生动物 MicroRNAs。
Cell. 2018 Mar 22;173(1):20-51. doi: 10.1016/j.cell.2018.03.006.
8
Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity.古生菌裂解病毒编码的抗 CRISPR 蛋白抑制 I 型 D 免疫。
Nat Microbiol. 2018 Apr;3(4):461-469. doi: 10.1038/s41564-018-0120-z. Epub 2018 Mar 5.
9
Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.哺乳动物 MicroRNAs 在基因调控、免疫和癌症中的核功能。
Mol Cancer. 2018 Feb 22;17(1):64. doi: 10.1186/s12943-018-0765-5.
10
CRISPR Genome Engineering for Human Pluripotent Stem Cell Research.用于人类多能干细胞研究的CRISPR基因组工程
Theranostics. 2017 Oct 7;7(18):4445-4469. doi: 10.7150/thno.18456. eCollection 2017.